132 related articles for article (PubMed ID: 26062048)
1. I. Hodgkin lymphoma: special challenges and solutions.
Connors JM
Hematol Oncol; 2015 Jun; 33 Suppl 1():21-4. PubMed ID: 26062048
[No Abstract] [Full Text] [Related]
2. Hodgkin lymphoma in Africa: present and future.
Stefan DC
Transfus Apher Sci; 2013 Oct; 49(2):144-6. PubMed ID: 23953134
[TBL] [Abstract][Full Text] [Related]
3. [Hodgkin lymphoma (Hodgkin disease)].
Naumann UK; Käser L; Vetter W
Praxis (Bern 1994); 2006 Nov; 95(44):1697-703; quiz 1704, 1706. PubMed ID: 17111877
[No Abstract] [Full Text] [Related]
4. XVIII. Management of nodular lymphocyte predominant Hodgkin lymphoma.
Advani RH; Hoppe RT
Hematol Oncol; 2015 Jun; 33 Suppl 1():90-5. PubMed ID: 26062064
[No Abstract] [Full Text] [Related]
5. [Changing patterns in the clinical, pathological features of Hodgkin lymphoma].
Miltényi Z; Simon Z; Páyer E; Váróczy L; Gergely L; Jóna A; Illés A
Orv Hetil; 2010 Dec; 151(49):2011-8. PubMed ID: 21106481
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Hodgkin lymphoma: a 50-year perspective.
Canellos GP; Rosenberg SA; Friedberg JW; Lister TA; Devita VT
J Clin Oncol; 2014 Jan; 32(3):163-8. PubMed ID: 24441526
[No Abstract] [Full Text] [Related]
7. XVII. Treatment of advanced-stage Hodgkin lymphoma.
Engert A
Hematol Oncol; 2015 Jun; 33 Suppl 1():87-9. PubMed ID: 26062063
[No Abstract] [Full Text] [Related]
8. XVI. Early stage Hodgkin lymphoma.
Radford J
Hematol Oncol; 2015 Jun; 33 Suppl 1():84-6. PubMed ID: 26062062
[No Abstract] [Full Text] [Related]
9. Nasopharyngeal Hodgkin lymphoma.
Johnson ME; Robu VG; Turaka A
J Clin Oncol; 2014 Apr; 32(11):e40-1. PubMed ID: 24449240
[No Abstract] [Full Text] [Related]
10. Intracerebral progression of Hodgkin lymphoma in a man with HIV.
Saloura V; Grivas PD; Mapow D; Kazmi K; Ward K; Styler M
Postgrad Med; 2009 Nov; 121(6):170-5. PubMed ID: 19940428
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis and treatment of nodular lymphocyte predominant Hodgkin lymphoma].
Nagai H
Nihon Rinsho; 2012 Apr; 70 Suppl 2():561-7. PubMed ID: 23134016
[No Abstract] [Full Text] [Related]
12. [Primarily detected lymphogranulomatosis].
Ardashev VN; Kizhaev EV; Zav'ialov MS
Voen Med Zh; 2000 Feb; 321(2):41-8. PubMed ID: 10870447
[No Abstract] [Full Text] [Related]
13. [Malignant lymphoma in pediatrics].
Ise T
Rinsho Hoshasen; 1985 Oct; 30(11):1415-25. PubMed ID: 3910879
[No Abstract] [Full Text] [Related]
14. Hodgkin lymphoma and the impact of age.
Armitage JO
Oncology (Williston Park); 2008 Nov; 22(12):1379, 1385. PubMed ID: 19322947
[No Abstract] [Full Text] [Related]
15. Hodgkin disease/lymphoma.
Hoppe RT; Advani RH; Ambinder RF; Bierman PJ; Bloomfield CD; Blum K; Dabaja B; Djulbegovic B; Forero A; Gordon LI; Hernandez-Ilizaliturri FJ; Hudson MM; Kaminski MS; Love G; Maloney DG; Mansur D; Mauch PM; Moore JO; Schilder RJ; Weiss LM; Winter JN; Yahalom J; Zelenetz AD;
J Natl Compr Canc Netw; 2008 Jul; 6(6):594-622. PubMed ID: 18597713
[No Abstract] [Full Text] [Related]
16. T-cell/histiocyte-rich large B-cell lymphoma--transformation of nodular lymphocyte predominant Hodgkin lymphoma in the bone marrow.
Eyre TA; King AJ; Hatton C; Collins GP
Eur J Haematol; 2014 Jun; 92(6):550-1. PubMed ID: 24483596
[No Abstract] [Full Text] [Related]
17. [Malignant lymphoma in children].
Leverger G; Frappaz D; Patte C; Philip T
Rev Prat; 1993 Nov; 43(17):2177-81. PubMed ID: 8146532
[TBL] [Abstract][Full Text] [Related]
18. Developments in the management of Hodgkin's lymphoma.
Lowry L; Hoskin P; Linch D
Lancet; 2010 Mar; 375(9717):786-8. PubMed ID: 20171729
[No Abstract] [Full Text] [Related]
19. Hodgkin's and non-Hodgkin's lymphomas.
McElwain TJ
Br J Hosp Med; 1984 Jan; 31(1):10-4, 18-9. PubMed ID: 6697038
[No Abstract] [Full Text] [Related]
20. [Clinically relevant prognostic factors in malignant lymphoma].
Engelhard M; Löffler M
Internist (Berl); 1993 Feb; 34(2):127-31. PubMed ID: 8454425
[No Abstract] [Full Text] [Related]
[Next] [New Search]